Dermata Therapeutics Inc. (DRMAW)
NASDAQ: DRMAW
· Real-Time Price · USD
0.02
0.00 (29.03%)
At close: Jun 09, 2025, 3:06 PM
Dermata Therapeutics Income Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -11.65M | -12.51M | -11.53M | -10.12M | -8.97M | -8.04M | -7.53M | -8.17M | -9.17M | -9.67M | -10.52M | -9.78M | -8.38M | -7.86M | -5.8M | -4.62M | -4.09M |
Interest Income | 192.7K | 225.78K | 262.29K | 302.56K | 278.97K | 247.22K | 203.44K | 132.16K | 101.11K | 63.57K | 21.49K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -11.46M | -12.29M | -11.27M | -9.82M | -8.69M | -7.79M | -7.33M | -8.04M | -9.06M | -9.61M | -10.49M | -9.78M | -8.38M | -7.9M | -5.75M | -4.63M | -4.12M |
Net Income | -11.46M | -12.29M | -11.27M | -9.82M | -8.69M | -7.79M | -7.25M | -7.91M | -8.94M | -9.48M | -10.45M | -9.78M | -8.38M | -7.9M | -5.75M | -4.63M | -4.12M |
Selling & General & Admin | 3.77M | 4.31M | 4.39M | 4.47M | 4.49M | 3.97M | 3.71M | 3.69M | 3.92M | 4.02M | 4.64M | 4.66M | 4.01M | 4.4M | 3.33M | 2.84M | 2.76M |
Research & Development | 7.88M | 8.2M | 7.15M | 5.65M | 4.48M | 4.07M | 3.82M | 4.47M | 5.25M | 5.65M | 5.87M | 5.12M | 4.37M | 3.46M | 2.46M | 1.78M | 1.33M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 11.65M | 12.51M | 11.53M | 10.12M | 8.97M | 8.04M | 7.53M | 8.17M | 9.17M | 9.67M | 10.52M | 9.78M | 8.38M | 7.86M | 5.8M | 4.62M | 4.09M |
Interest Expense | n/a | n/a | 37.54K | 37.54K | 37.54K | 37.54K | 42.09K | 63.57K | 63.57K | 63.57K | 45.59M | 45.57M | 45.57M | 45.61M | 84.09K | 140.77K | 167.81K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.31M | 12.51M | 11.53M | 10.12M | 8.97M | 8.04M | 7.53M | 8.17M | 9.17M | 9.67M | 10.52M | 9.78M | 8.38M | 7.86M | 5.8M | 4.62M | 4.09M |
Income Tax Expense | 3.2M | n/a | -3.21M | -3.21M | -3.21M | -5.76K | -87.72K | -128.88K | -2.86M | -5.64M | -51.13M | -51.08M | -48.35M | -45.57M | 78.22K | 25.55K | -25.49K |
Shares Outstanding (Basic) | 5.15M | 1.55M | 1.55M | 676.57K | 444.06K | 3.93M | 3.19M | 2.7M | 65.72K | 770.12K | 767.27K | 699.68K | 520.54K | 8.35M | 311.27K | 469.74K | 520.54K |
Shares Outstanding (Diluted) | 5.15M | 1.55M | 1.55M | 676.57K | 444.06K | 3.93M | 3.19M | 2.7M | 65.72K | 770.12K | 767.27K | 699.68K | 522.03K | 8.35M | 311.27K | 469.74K | 520.54K |
EPS (Basic) | -8.71 | -15.32 | -13.82 | -12.32 | -8.77 | -35.79 | -37.31 | -39.87 | -43.14 | -14.41 | -12.66 | -15.06 | -14 | -13.08 | -12.82 | -8.47 | -7.21 |
EPS (Diluted) | -8.71 | -15.32 | -13.82 | -12.32 | -8.77 | -35.79 | -37.31 | -39.87 | -43.14 | -14.4 | -12.65 | -15.05 | -13.99 | -13.08 | -12.82 | -8.47 | -7.21 |
EBITDA | -11.65M | -9.31M | -8.24M | -6.83M | -5.68M | -7.96M | -5.82M | -6.46M | -7.45M | -7.96M | -10.52M | -9.78M | -8.38M | -7.86M | -5.66M | -4.49M | -3.95M |
EBIT | -9.31M | -12.51M | -11.53M | -10.12M | -8.97M | -8.04M | -7.53M | -8.17M | -9.17M | -9.67M | -10.52M | -9.78M | -8.38M | -7.86M | -5.66M | -4.49M | -3.95M |
Depreciation & Amortization | n/a | 3.2M | 5.42M | 7.24M | 8.97M | 5.76M | 5.26M | 5.89M | 6.89M | 9.67M | 7.96M | 5.52M | 2.79M | 324.00 | 133.84K | 186.5K | 237.54K |